Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study

被引:18
|
作者
Finlay, Andrea K. [1 ,2 ]
Morse, Erica [3 ]
Stimmel, Matthew [4 ]
Taylor, Emmeline [1 ,5 ]
Timko, Christine [1 ,6 ]
Harris, Alex H. S. [1 ,7 ]
Smelson, David [8 ]
Yu, Mengfei [1 ]
Blue-Howells, Jessica [4 ]
Binswanger, Ingrid A. [3 ,9 ,10 ]
机构
[1] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat Ci2i, 795 Rd MPD-152, Willow, CA 94025 USA
[2] Natl Ctr Homelessness Vet, Dept Vet Affairs, 795 Willow Rd, Menlo Pk, CA 94025 USA
[3] Kaiser Permanente, Inst Hlth Res, Denver, CO USA
[4] US Dept Vet Affairs, Vet Justice Programs, Menlo Pk, CA USA
[5] Univ Colorado, Dept Clin Psychol, Colorado Springs, CO 80907 USA
[6] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[7] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA
[8] Edith Nourse Rogers VA Med Ctr, Ctr Org & Implementat Sci, Bedford, MA USA
[9] Colorado Permanente Med Grp, Denver, CO USA
[10] Univ Colorado, Div Gen Internal Med, Sch Med, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
opioid-related disorders; pharmacotherapy; veterans; criminal justice; ALCOHOL-USE DISORDER; SUBSTITUTION TREATMENT; ASSISTED TREATMENT; MAINTENANCE TREATMENT; PHARMACOTHERAPY; METHADONE; BUPRENORPHINE; RELEASE; IMPLEMENTATION; FACILITATORS;
D O I
10.1007/s11606-020-05944-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Veterans involved in the legal system are at high risk for overdose but have lower receipt of medications for opioid use disorder than other veterans. Objective The study aimed to understand barriers to medication access from the perspective of legally involved veterans with opioid use disorder and people who work with these veterans in the Veterans Health Administration (VHA) and the legal system. Design This national qualitative study interviewed veterans and stakeholders from 14 geographically diverse VHA facilities to explore perceptions of barriers to medications for opioid use disorder. Participants Participants included veterans with a history of opioid use disorder and legal involvement (n= 18), VHA Veterans Justice Programs Specialists (n= 15), VHA and community substance use disorder treatment providers (n= 5), and criminal justice staff (n= 12). Approach We conducted interviews based on the Consolidated Framework for Implementation Research. Interview transcripts were analyzed using a team-based approach. Key Results Four key barriers, noted by group, were identified: (1) a preference for counseling along with or instead of medications (veterans, Specialists, treatment providers, criminal justice staff); (2) concerns about veterans using medications without a prescription, selling them, or providing them to others (veterans, Specialists, treatment providers, criminal justice staff); (3) concerns about perceived stigma towards medication use (veterans, Specialists, treatment providers, criminal justice staff); and (4) concerns about medication discontinuation after recurrent opioid use (veterans, criminal justice staff). A fifth theme, education, was noted by all stakeholders except providers as important to facilitating use of medications for opioid use disorder. All five themes mapped to the framework construct of knowledge and beliefs about the intervention. Conclusions Based on identified barriers, interventions focused on enhancing medication knowledge, reducing stigma towards use of medications, and increasing knowledge that opioid use may recur during treatment may help increase access to medication for veterans with legal involvement.
引用
收藏
页码:2529 / 2536
页数:8
相关论文
共 50 条
  • [21] Mobile Units Improve Access to Medications for Opioid Use Disorder: A Qualitative Implementation Study
    Chatterjee, Avik
    Baker, Trevor
    Rudorf, Maria
    Walt, Galya
    Stotz, Caroline
    Martin, Anna
    Kinnard, Elizabeth
    McAlearney, Ann
    Bosak, Julie
    Medley, Bethany
    Samet, Jeffrey
    Lunze, Karsten
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [22] Barriers to medications for opioid use disorder in the court system: provider availability, provider "trustworthiness," and cost
    Ahmed, Fatema Z.
    Andraka-Christou, Barbara
    Clark, M. H.
    Totaram, Rachel
    Atkins, Danielle N.
    del Pozo, Brandon
    HEALTH & JUSTICE, 2022, 10 (01)
  • [23] Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
    Fatema Z. Ahmed
    Barbara Andraka-Christou
    M.H. Clark
    Rachel Totaram
    Danielle N. Atkins
    Brandon del Pozo
    Health & Justice, 10
  • [24] Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care
    Tofighi, Babak
    Williams, Arthur Robin
    Chemi, Chemi
    Sindhu, Selena
    Dickson, Vicky
    Lee, Joshua D.
    SUBSTANCE USE & MISUSE, 2019, 54 (14) : 2409 - 2419
  • [25] Breastfeeding Motivators and Barriers in Women Receiving Medications for Opioid Use Disorder
    Yonke, Nicole
    Yakes Jimenez, Elizabeth
    Leeman, Lawrence
    Leyva, Yuridia
    Ortega, Alyssa
    Bakhireva, Ludmila N.
    BREASTFEEDING MEDICINE, 2020, 15 (01) : 17 - 23
  • [26] Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis
    Mcneely, Heidi L.
    Schreiber, Terri L.
    Swann, William L.
    Amura, Claudia R.
    HEALTH & JUSTICE, 2024, 12 (01)
  • [27] Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staff
    Hannah K. Knudsen
    Shaquita Andrews-Higgins
    Sandra Back-Haddix
    Michelle R. Lofwall
    Laura Fanucchi
    Sharon L. Walsh
    Substance Abuse Treatment, Prevention, and Policy, 20 (1)
  • [28] The Role of Perceived, Enacted, and Internalized Stigma on the Uptake of Medications for Opioid Use Disorder (MOUD) Among Women in the Criminal Legal System
    Quadri, Oluwaseyi
    Skogseth, Emma
    Brant, Kristina
    Harrison, Eric
    Jones, Abenaa
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [29] Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders
    Victor, Grant
    Lee, Guijin
    del Pozo, Brandon
    Silverstein, Sydney
    Zettner, Catherine
    Cason, Rahni
    Ray, Bradley
    JOURNAL OF DRUG ISSUES, 2022, 52 (03) : 389 - 405
  • [30] Variation in intervention stigma among medications for opioid use disorder
    Madden, Erin F.
    Barker, Kristin K.
    Guerra, Joshua
    Villanueva, Corey
    Sulzer, Sandra H.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2